Terminalia chebula Therapeutic effects in Patients With Symptomatic Hemorrhoids

Terminalia chebula Therapeutic effects in Patients With Symptomatic Hemorrhoids in reducing hemorrhage

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190915044780N1

Enrollment

Registered

2020-05-09

Start date

2020-06-21

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoids. Hemorrhoids and perianal venous thrombosis

Interventions

Intervention 1: Intervention group: In the intervention group standard treatment (lifestyle modification including high fiber diet, intake of more liquids, forcing during excretion, personal hygiene t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Internal hemorrhoids Patient hemorrhoids grade one, two and three Having informed written consent to participate in the study

Exclusion criteria

Exclusion criteria: Internal Grade Four Hemorrhoids external hemorrhoid Systemic disease anal fissure anal abscess anal fistula cirrhosis Inflammatory bowel disease (IBD) Those who have not received the full course of treatment or are experiencing medical complications.

Design outcomes

Primary

Measure	Time frame
Severity of hemorrhage. Timepoint: At the beginning of treatment and then weekly for 3 weeks. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Zabihi Mahmoudabadi

Tehran University of Medical Sciences

hzabihim@tums.ac.ir+98 21 6675 7001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026